Houston Methodist is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine. Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This website uses cookies to improve website functionality and performance, to analyze website traffic, and to provide you with a more personalized experience. To find out more about the cookies we use, see our Digital Privacy Policy, Disclaimer & Terms of Use.

Cytopathology and Small Biopsy Update - 02.17.24

From CME Admin

views

Cytopathology and Small Biopsy Update

Physicians and cytologists need the most up-to-date knowledge and strategies in pathology and cytopathology to provide the most appropriate ancillary testing for guiding patient management. With the current update, attendees will learn about the various new evidence-based reporting terminologies or updates to previously existing ones. This will enable them to assess the patient’s risk of malignancy, specifically regarding findings in thyroid, salivary, pancreas, biliary tract, and respiratory tract. By understanding these new site-specific reporting systems, attendees will know the risk of malignancy associated with each reporting category and appropriate ancillary testing and, therefore, better guide management of patients. The World Health Organization, under the guidance of the International Academy of Cytology, and other organizations is currently in the process of publishing cytology reporting terminologies across a broad spectrum of sites. Update and status reports on these will be provided. Additionally, digital cytology and whole slide imaging is the next big thing. A lecture, as to how they apply specifically to cytologic and small specimens will be presented. The status of whole slide imaging in the United States and around the world will be presented. Patient safety issues, updates to HPV testing, head and neck cancers, respiratory tract EBVs and molecular testing, cellblocks, and Rapid On-site Evaluation will be presented. Other new developments in the field that will impact patient care in the future will also be discussed.

Tags

Cytopathology and Small Biopsy Update - 02.17.24

Related Media